The M&A news came as Medtronic also released an earnings report summing up its fiscal year 2023, which ended April 28. Altogether, the company took in more than $31.2 billion for the year. Though ...

Major medical device manufacturing company Medtronic has announced a US Food and Drugs Administration (FDA) class I recall of its MiniMed insulin pump system. This announcement comes during ...

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

GALWAY, Ireland, Oct. 4, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global ...

Medtronic's Adapt trial put the algorithm-equipped MiniMed 780G insulin pump to the test against one standard of care for Type 1 diabetes.

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

Arecor Therapeutics plc(“Arecor” or the “Company”) ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to ...

Medtronic’s diabetes products are sold directly to patients and consist of wearable and disposable devices. ... The letter delayed the FDA’s clearance of the MiniMed 780G insulin pump until 2023.

However, insulin pump over- and under-delivery with atmospheric change isn’t unique to Medtronic’s products, as Medscape Medical News reported in 2024 and in 2016. The phenomenon was described ...

ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to fund Arecor's development of Arestat enabled novel, high ...

Insulin pumps are wearable devices that people with diabetes use to deliver insulin. They are connected to a spot on your body and continuously give insulin for 2 to 4 days. An insulin pump is a ...